Largest Private Hospital in Turkey Performs 1st Implant of SynCardia's Total Artificial Heart
Florence Nightingale Hospital in Istanbul Saves 45-Year-Old Man Suffering from Congestive Heart Failure for Past 10 Years
TUCSON, Ariz. – April 5, 2011 – On March 21, Florence Nightingale Hospital in Istanbul, Turkey, performed its first implant of SynCardia's Total Artificial Heart.
"This was the ideal device for our patient," said implanting surgeon Prof. Dr. Deniz Suha Kucukaksu. "Now he can be bridged to cardiac transplantation under very safe conditions. We are confident with our patient's progress and expect this case to be the first successful Total Artificial Heart implant in Turkey. We appreciate the extensive support from SynCardia and its local distributor."
Omer Bayrak, 45, had been suffering from congestive heart failure since 2001. Four years ago, he underwent cardiac resynchronization therapy and received an implantable cardioverter-defibrillator (ICD). Last year, he was hospitalized 11 times for inotropic support.
For 15 days prior to implant, Mr. Bayrak had been in the cardiac intensive care unit. He was listed on the urgent list for heart transplantation but a matching donor heart wasn't available. His cardiac function continued to worsen and doctors decided he was an ideal patient to receive SynCardia's Total Artificial Heart. Since it was the hospital's first implant, the surgery was proctored by experienced Total Artificial Heart surgeon Dr. Latif Arusoglu from the Heart & Diabetes Center NRW in Bad Oeynhausen, Germany.
There are currently more than 500 people in Turkey in NYHA Class III & IV heart failure who are listed for transplant. The average waiting time for a donor heart in Turkey is approximately 10 months.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the temporary Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, firstname.lastname@example.org, (520) 547-7463